Greystone Managed Investments’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-245,481
Closed -$16.5M 79
2015
Q2
$16.5M Sell
245,481
-97,840
-28% -$6.39M 0.43% 62
2015
Q1
$20.1M Sell
343,321
-12,330
-3% -$745K 0.46% 62
2014
Q4
$23.3M Sell
355,651
-122,796
-26% -$7.74M 0.49% 56
2014
Q3
$27.6M Buy
+478,447
New +$26.6M 0.55% 46

Other funds holding ABBV

Greystone Managed Investments's ABBV Position: Q3 2015 in Review

Greystone Managed Investments sold out of AbbVie (ABBV) in Q3 2015, closing a stake of 245,481 shares — an estimated $16.5M sold.

Greystone Managed Investments first reported a position in ABBV in Q3 2014 and held it in 4 quarters. The position peaked at $27.6M in Q3 2014. 1,605 funds tracked by Wall St. Rank hold ABBV as of Q3 2015.

  • Greystone Managed Investments reported no remaining AbbVie position as of Q3 2015 after selling out during the quarter.
  • Greystone Managed Investments sold 245,481 AbbVie shares in Q3 2015, an estimated $16.5M.
  • Greystone Managed Investments first reported a position in AbbVie in Q3 2014 and held it in 4 quarters.
  • Greystone Managed Investments's AbbVie position peaked at $27.6M in Q3 2014.
  • 1,605 funds tracked by Wall St. Rank held AbbVie as of Q3 2015.

Based on Greystone Managed Investments's 13F filing for Q3 2015, filed 4 Nov 2015.